Back to Search Start Over

Expression of an active Gα s mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance.

Authors :
Zhao X
Deng P
Iglesias-Bartolome R
Amornphimoltham P
Steffen DJ
Jin Y
Molinolo AA
de Castro LF
Ovejero D
Yuan Q
Chen Q
Han X
Bai D
Taylor SS
Yang Y
Collins MT
Gutkind JS
Source :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Jan 16; Vol. 115 (3), pp. E428-E437. Date of Electronic Publication: 2017 Dec 27.
Publication Year :
2018

Abstract

Fibrous dysplasia (FD) is a disease caused by postzygotic activating mutations of GNAS (R201C and R201H) that encode the α-subunit of the G <subscript>s</subscript> stimulatory protein. FD is characterized by the development of areas of abnormal fibroosseous tissue in the bones, resulting in skeletal deformities, fractures, and pain. Despite the well-defined genetic alterations underlying FD, whether GNAS activation is sufficient for FD initiation and the molecular and cellular consequences of GNAS mutations remains largely unresolved, and there are no currently available targeted therapeutic options for FD. Here, we have developed a conditional tetracycline (Tet)-inducible animal model expressing the Gα <subscript>s</subscript> <superscript>R201C</superscript> in the skeletal stem cell (SSC) lineage (Tet-Gα <subscript>s</subscript> <superscript>R201C</superscript> / Prrx1 -Cre/LSL-rtTA-IRES-GFP mice), which develops typical FD bone lesions in both embryos and adult mice in less than 2 weeks following doxycycline (Dox) administration. Conditional Gα <subscript>s</subscript> <superscript>R201C</superscript> expression promoted PKA activation and proliferation of SSCs along the osteogenic lineage but halted their differentiation to mature osteoblasts. Rather, as is seen clinically, areas of woven bone admixed with fibrous tissue were formed. Gα <subscript>s</subscript> <superscript>R201C</superscript> caused the concomitant expression of receptor activator of nuclear factor kappa-B ligand (Rankl) that led to marked osteoclastogenesis and bone resorption. Gα <subscript>s</subscript> <superscript>R201C</superscript> expression ablation by Dox withdrawal resulted in FD-like lesion regression, supporting the rationale for Gα <subscript>s</subscript> -targeted drugs to attempt FD cure. This model, which develops FD-like lesions that can form rapidly and revert on cessation of mutant Gα <subscript>s</subscript> expression, provides an opportunity to identify the molecular mechanism underlying FD initiation and progression and accelerate the development of new treatment options.<br />Competing Interests: The authors declare no conflict of interest.<br /> (Copyright © 2018 the Author(s). Published by PNAS.)

Details

Language :
English
ISSN :
1091-6490
Volume :
115
Issue :
3
Database :
MEDLINE
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
29282319
Full Text :
https://doi.org/10.1073/pnas.1713710115